Gary Fishbein has extensive experience in the pharmaceutical and clinical research industry. Gary began their career at PharmaNet in 2005, where they worked as a Senior Medical Director until 2012. Gary then joined ICON plc as a Senior Medical Director and held that position until 2020. In 2020, they transitioned to Worldwide Clinical Trials, first as an Executive Medical Director and later as the Vice President and Therapeutic Area Lead for Oncology.
Gary Fishbein attended Thomas Jefferson University from 1981 to 1985. No specific degree or field of study was mentioned.
July, 2022 - present
December, 2020